Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01505049 · ClinicalTrials.gov registry record
Immune Memory After Papillomavirus Vaccination
A clinical trial of Healthy Volunteers, sponsored by Emory University.
- Completed
- Registry status
- 203
- Enrollment target
- 1
- Study location
NCT01505049: Completed study of Healthy Volunteers, sponsored by Emory University.
NCT01505049 is a study of Healthy Volunteers that has completed, run by Emory University. The registered enrollment target is 203 participants, below the 481-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01505049, a study of Healthy Volunteers, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 203 participants
- Enrollment target
- 1
- Study location
Study Summary
Vaccines for human papillomavirus (HPV) have been available in the United States since 2006. Early studies have shown a high rate of effectiveness of these vaccines, however it is not known how long this protection will last. The IMAP study will look at various parts of the immune system and potential markers for long lived immune responses to this vaccine.
Conditions Studied
Interventions
- DRUG quadrivalent HPV vaccine
Study Locations (1)
Georgia
- Emory University - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2012-01 |
| Est. Completion | 2015-01 |
What the finished NCT01505049 record still lists
NCT01505049 is an observational study that tracks outcomes without assigning an intervention. The registered 203 participants enrollment target is mid-sized for trials with a published cap, below the 481-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (58% lower).
The record links to 1 condition, with Healthy Volunteers appearing as the primary indexed condition, and to 1 intervention - of which quadrivalent HPV vaccine is the first listed.
NCT01505049 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT01505049 about?
NCT01505049 is a clinical study titled "Immune Memory After Papillomavirus Vaccination". Vaccines for human papillomavirus (HPV) have been available in the United States since 2006. Early studies have shown a high rate of effectiveness of these vaccines, however it is not known how long this protection will last. The IMAP study will look at various parts of the immune system and potenti...
What is the current status of trial NCT01505049?
This trial is currently completed. The enrollment target is 203 participants. The study started on 2012-01. Estimated completion is 2015-01.
What conditions does trial NCT01505049 study?
This clinical trial studies the following conditions: Healthy Volunteers.
What interventions are being tested in trial NCT01505049?
The interventions under investigation include: quadrivalent HPV vaccine (DRUG).
Who is sponsoring clinical trial NCT01505049?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01505049 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01505049's enrollment target sits among peer trials
203 45th of 283 higher than 237 of 283 other Healthy Volunteers trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Volunteers trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Adaptive Optics Retinal Imaging
RECRUITING
-
A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia
RECRUITING · Phase 1
-
Acute Effects of High-intensity Interval Training With Mindfulness-based Recovery on Executive Function in Children
RECRUITING · NA
-
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.
RECRUITING · Phase 1
-
Children s Growth and Behavior Study
RECRUITING
-
New Heart Imaging Techniques to Evaluate Possible Heart Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05652686 · 203 participants · Phase 1
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
- NCT06063122 · 203 participants · NA
Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants
- NCT07031245 · 203 participants · NA
Evidence-Based Quality Improvement to Reduce VA Primary Care Burnout
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia